These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 343873)

  • 21. Policy to reduce the risk costs the environment dear.
    Hotchkiss J
    BMJ; 2008 Sep; 337():a1776. PubMed ID: 18812377
    [No Abstract]   [Full Text] [Related]  

  • 22. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tateishi J; Tashima T; Kitamoto T
    Ann Neurol; 1988 Sep; 24(3):466. PubMed ID: 3067656
    [No Abstract]   [Full Text] [Related]  

  • 23. Decontamination of Creutzfeldt-Jakob disease agent: current strategies.
    Taylor DM
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):237. PubMed ID: 1891068
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inactivation and removal of prions in producing medical products. A contribution to evaluation and declaration of possible methods].
    Bertram J; Mielke M; Beekes M; Lemmer K; Baier M; Pauli G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):36-40. PubMed ID: 15205822
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Variant Creutzfeld-Jakob Disease and Ophthalmologic Surgery" Committee of the German Society of Ophthalmologic Surgeons advises: current information on application of "Variant Creutzfeld-Jakob Disease Guidelines" of the Robert Koch Institute to ophthalmologic surgery].
    Lemmen KD
    Klin Monbl Augenheilkd; 2003 May; 220(5):366-8. PubMed ID: 12838933
    [No Abstract]   [Full Text] [Related]  

  • 26. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 27. Contamination of human growth hormone with Creutzfeldt-Jakob disease agent.
    Taylor DM
    Biomed Pharmacother; 1987; 41(5):255. PubMed ID: 3311193
    [No Abstract]   [Full Text] [Related]  

  • 28. Thinking about eye instruments and CJD.
    Reichert M; Schultz JK
    OR Manager; 2003 Jan; 19(1):22-3. PubMed ID: 12555721
    [No Abstract]   [Full Text] [Related]  

  • 29. New prion inactivation treatment presented.
    Health Estate; 2007 Jun; 61(6):52-3. PubMed ID: 17724956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion inactivation and medical instrument reprocessing: challenges facing healthcare facilities.
    Sehulster LM
    Infect Control Hosp Epidemiol; 2004 Apr; 25(4):276-9. PubMed ID: 15108722
    [No Abstract]   [Full Text] [Related]  

  • 31. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observance of Sterilization Protocol Guideline Procedures of Critical Instruments for Preventing Iatrogenic Transmission of Creutzfeldt-Jakob Disease in Dental Practice in France, 2017.
    Bourgeois D; Dussart C; Saliasi I; Laforest L; Tramini P; Carrouel F
    Int J Environ Res Public Health; 2018 Apr; 15(5):. PubMed ID: 29693615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection control. Mad cows and weird science.
    Shimkus J
    Hosp Health Netw; 1998 Jun; 72(11):62. PubMed ID: 9691953
    [No Abstract]   [Full Text] [Related]  

  • 34. CJD: how to process instruments.
    Reichert M; Schultz JK
    OR Manager; 2001 Jul; 17(7):21-2. PubMed ID: 11467167
    [No Abstract]   [Full Text] [Related]  

  • 35. Creutzfeldt-Jakob disease agent.
    Taylor DM
    Infect Control Hosp Epidemiol; 1988 Dec; 9(12):526. PubMed ID: 3069904
    [No Abstract]   [Full Text] [Related]  

  • 36. Iatrogenic vCJD from surgical instruments.
    Frosh A; Joyce R; Johnson A
    BMJ; 2001 Jun; 322(7302):1558-9. PubMed ID: 11431283
    [No Abstract]   [Full Text] [Related]  

  • 37. [Variant Creutzfeldt-Jakob disease. Epidemiology, detection, diagnosis and prevention with special reference to minimizing risk of iatrogenic transmission by medical products, especially surgical instruments. Report of the Variant Creutzfeldt-Jakob Disease Task Force on this topic].
    HNO; 2002 Apr; 50(4):296-315. PubMed ID: 12063688
    [No Abstract]   [Full Text] [Related]  

  • 38. Product Study. Disposing of the CJD threat.
    Cys J
    Mater Manag Health Care; 2002 Feb; 11(2):27. PubMed ID: 11922034
    [No Abstract]   [Full Text] [Related]  

  • 39. Hospitals to spend 200m pounds sterling to prevent spread of vCJD.
    Dyer O
    BMJ; 2001 Jan; 322(7278):68. PubMed ID: 11271162
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mad cow disease and the new variant of Creutzfeldt-Jakob disease].
    Pastoret PP
    Rev Med Liege; 2001 Aug; 56(8):567-71. PubMed ID: 11584442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.